In a letter to WADA's executive committee in Montreal, Denis Oswald, president of the Association of Summer Olympic International Federations (ASOIF), and Sergei Bubka, the International Olympic Committee's (IOC) athlete's commission chief, have accused the French anti-doping laboratory in Châtenay-Malabry for violating confidentiality regulations and called for an investigation to identify the person/s who leaked one of the documents that ultimately led to the doping allegations brought against seven-time Tour winner Lance Armstrong.
"According to the world code, that laboratory should have ensured the anonymity of the samples used in their research, or asked the athletes concerned for permission to perform [post] analyses. It's not a question of protecting anyone, but of applying the rules," said Oswald to L'Equipe, the paper that originally published evidence that linked six of Armstrong's frozen urine samples from the 1999 Tour de France to artificial or recombinant EPO, following retrospective testing by the lab in Châtenay-Malabry. Oswald and Bubka have also asked that the lab be suspended.
